Home Limited usefulness of the PFA-100™ for the monitoring of ADP receptor antagonists–in vitro experience
Article
Licensed
Unlicensed Requires Authentication

Limited usefulness of the PFA-100™ for the monitoring of ADP receptor antagonists–in vitro experience

  • Jacek Golanski , Justyna Pluta , Janina Baraniak and Cezary Watala
Published/Copyright: June 1, 2005

Abstract

We have evaluated the usefulness of the PFA-100™ system (collagen/ADP and collagen/epinephrine cartridges) to assess the in vitro effects of a few platelet function inhibitors: Aspisol® (60 μg/ml), 4-[4-[4-(aminoiminomethyl]-1-piperazinyl]-1-piperidineactetic acid, hydrochloride trihydrate (GR144053F, fibrinogen receptor antagonist, 100 nM), adenosine-3′,5′-diphosphate (A3P5P, P2Y1 ADP receptor antagonist, 500 μM) and Bis[(adenosine-5′-O-phosphorodithioyl) methylene]-phosphinic acid (APTMPA, P2Y12 ADP receptor antagonist, 500 μM) on platelet function, as compared with the other commonly used diagnostic technique, a whole blood electrical aggregometry (20 μM ADP-or 0.5 mM arachidonic acid). The in vitro studies were carried out on a group of 38 subjects. Whereas all the examined platelet antagonists and inhibitors almost completely blocked the 20 mM ADP-or 0.5 mM arachidonic acid-induced (in the case of acetylsalicylic acid) whole blood aggregation, only two inhibitors (Aspisol® and GR144053F) remained effective in a significant prolongation of the PFA-100™ occlusion time. Otherwise, using the PFA-100™ system we were not able to detect the inhibitory actions of ADP receptor antagonists–P2Y1 and P2Y12. Our findings point to a limited usefulness of the PFA-100™ system for the monitoring of the effectiveness of ADP receptor antagonists. The outcomes of this study show that platelet aggregometry in whole blood is characterised by the highest sensitivity in the monitoring of the investigated blood platelet inhibitors.

Published Online: 2005-6-1
Published in Print: 2004-2-16

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. International collaboration in clinical chemistry and laboratory medicine: the Human Proteome Organization (HUPO) Plasma Proteome Project
  2. Current concepts in standardization of cardiac marker immunoassays
  3. Collagen, ageing and nutrition
  4. Evaluation of a new efficient procedure for single-nucleotide polymorphism genotyping: tetra-primer amplification refractory mutation system-polymerase chain reaction
  5. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy
  6. Limited usefulness of the PFA-100™ for the monitoring of ADP receptor antagonists–in vitro experience
  7. Isolation of plasma small-dense low-density lipoprotein using a simple air-driven ultracentrifuge and quantification using immunassay of apolipoprotein B
  8. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide
  9. Calcium oxalate crystallization in untreated urine, centrifuged and filtered urine and ultrafiltered urine
  10. Matrix effects in clinical immunoassays and the effect of preheating and cooling analytical samples
  11. Blood alcohol testing: comparison of the performance obtained with the different methods used in the Belgian external quality assessment schemes
  12. Determination of lipase catalytic activity in two reference materials: BCR 693 and BCR 694 by titrimetry at constant pH
  13. Evaluation of a new generation of plastic evacuated blood-collection tubes in clinical chemistry, therapeutic drug monitoring, hormone and trace metal analysis
  14. Association between the CYP2C9 polymorphism and the drug metabolism phenotype
  15. Analytical goals for coagulation tests based on biological variation
  16. In vivo total antioxidant capacity: comparison of two different analytical methods
  17. Performance evaluation of automated assays for β-CrossLaps, N-MID-Osteocalcin and intact parathyroidhormone (BIOROSE Multicenter Study)
  18. Evaluation of the blood gas analyzer GEM(r) PREMIER(tm) 3000
  19. Lactate dehydrogenase (LD) extra isoenzyme electrophoretic band between LD1 and LD2 caused by a complex with α1-lipoprotein. A case report
  20. Relationship between cryoglobulins and hepatitis C virus (HCV) core antigen or antibody titers
  21. Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter
  22. Biological variation of plasma chromogranin A
  23. Verification, validation and evaluation of analytical procedures in laboratory medicine
  24. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations
  25. Meetings and Awards
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.006/html
Scroll to top button